Skip to main content
Vitamin E · Normal: 5.5–17 mg/L · Optimal: 8–15 mg/L

What Is Vitamin E? Normal vs Optimal Range Explained

Vitamin E measures alpha-tocopherol, your body's primary fat-soluble antioxidant that protects cell membranes from oxidative damage. Labs accept 5.5–17 mg/L as normal, but optimal antioxidant protection and neurological function require 8–15 mg/L. Below 8 mg/L, nerve membrane integrity starts to decline. Above 15 mg/L, excess vitamin E may interfere with blood clotting and vitamin K function.

Want to check YOUR levels? Upload labs freeFree, 10 seconds →

Based on research by Alhajaji et al., Hormones (Athens, Greece) (2026). Data sourced from PubMed, CTD, FAERS. How we verify this data →
Sources verified as of April 2026
[01]

Normal vs Optimal Range

Lab Normal Range: 5.517 mg/L
Optimal: 815 mg/L
5.5 mg/L17 mg/L
Lab NormalOptimal

Lab ranges detect disease. Optimal ranges detect dysfunction before it becomes disease.

Range TypeLowHighUnit
Lab Normal5.517mg/L
Optimal815mg/L
[02]

Why Optimal Matters

The lab reference range for vitamin E stretches from 5.5 to 17 mg/L, but this broad window ignores a critical nuance: serum vitamin E travels on lipoproteins, so people with high cholesterol can have high vitamin E simply because they have more carrier molecules—not because their tissues are better protected. The CTD catalogs over 1,400 chemical-gene interactions involving alpha-tocopherol transfer protein (TTPA) and vitamin E metabolism pathways, reflecting how central this nutrient is to membrane protection across every organ system. Below 8 mg/L, lipid peroxidation in nerve cell membranes accelerates, producing the peripheral neuropathy and cerebellar ataxia that define clinical vitamin E deficiency. The optimal floor of 8 mg/L represents the threshold below which antioxidant protection of polyunsaturated fatty acids in neuronal membranes becomes insufficient. Interpreting vitamin E always requires checking it alongside lipid levels—a vitamin E-to-total-cholesterol ratio below 0.8 mg/g suggests true tissue deficiency.

Alhajaji et al. (2026, Hormones) conducted a systematic review and meta-analysis demonstrating the effectiveness of vitamin E supplementation in treating diabetic neuropathy, confirming that adequate alpha-tocopherol levels protect peripheral nerves from oxidative damage in high-glucose environments. PubMed indexes over 42,000 publications on vitamin E in human health, though the field has been complicated by large trials using synthetic dl-alpha-tocopherol rather than natural d-alpha-tocopherol—two forms with significantly different bioavailability and receptor binding. FAERS reports over 1,900 adverse events associated with high-dose vitamin E supplementation, predominantly bleeding complications in patients on concurrent anticoagulant therapy. The upper optimal limit of 15 mg/L provides a safety margin because doses producing levels above 15 mg/L inhibit vitamin K-dependent clotting factor activation, increasing hemorrhage risk in vulnerable populations.

Vitamin E deficiency in developed countries occurs almost exclusively from fat malabsorption rather than dietary inadequacy. Celiac disease, cystic fibrosis, Crohn's disease, chronic pancreatitis, and cholestatic liver diseases all impair the bile acid-mediated fat absorption that vitamin E requires for uptake. Abetalipoproteinemia—a rare genetic condition that prevents lipoprotein formation—causes severe vitamin E deficiency and progressive neurological damage from birth if not treated with massive supplementation doses. The neurological damage from vitamin E deficiency—spinocerebellar ataxia, peripheral neuropathy, and retinopathy—can become irreversible if left untreated, which distinguishes vitamin E from most other vitamin deficiencies where repletion fully reverses symptoms. This irreversibility makes maintaining levels in the 8–15 mg/L optimal range particularly important for anyone with a fat malabsorption condition.

Vitamin E supplementation demonstrates effectiveness in treating diabetic neuropathy, confirming that adequate alpha-tocopherol status protects peripheral nerve membranes from oxidative damage in metabolically stressed environments.
Alhajaji et al., Hormones (Athens, Greece) (2026)

Want to see where YOUR levels fall?

Upload labs free — instant results →
[03]

Symptoms When Low

Peripheral neuropathy—numbness, tingling, and loss of sensation in the hands and feetBalance problems and difficulty walking (cerebellar ataxia) from spinocerebellar degenerationMuscle weakness and wasting, particularly in proximal muscle groupsVisual problems and retinopathy from oxidative damage to the retinaImpaired immune response with increased susceptibility to infectionsFragile red blood cells (hemolytic anemia) from membrane lipid peroxidation
[04]

Symptoms When High

Increased bleeding risk from inhibition of vitamin K-dependent clotting factorsNausea, fatigue, and headache from very high supplementation doses above 1,000 IU dailyPotential interference with anticoagulant medications (warfarin, aspirin) amplifying bleed riskSome large trials suggested increased all-cause mortality at doses above 400 IU daily, though this remains debated
[05]

What Affects This Marker

Medications That Lower It

Medications That Raise It

[07]

FAQ

[08]

References

  1. [1]Alhajaji R, et al. Effectiveness of vitamin E in the treatment of diabetic neuropathy: systematic review and meta-analysis. Hormones (Athens, Greece). 2026. PMID: 41528693
  2. [2]Comparative Toxicogenomics Database (CTD): 1,400+ chemical-gene interactions involving alpha-tocopherol transfer protein (TTPA) and vitamin E metabolism pathways
  3. [3]PubMed: 42,000+ indexed publications on vitamin E in human health spanning antioxidant, neurological, and cardiovascular research
  4. [4]FDA Adverse Event Reporting System (FAERS): 1,900+ adverse events associated with vitamin E supplementation, predominantly bleeding complications with concurrent anticoagulation
  5. [5]Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academies Press. 2000
  6. [6]Traber MG. Vitamin E inadequacy in humans: causes and consequences. Advances in Nutrition. 2014;5(5):503-514
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Upload Your Lab Results

See where your levels fall on the optimal scale.

Upload Labs Free →